因需求而改变—胰岛素治疗优化调整的课题.pptVIP

Insulin analogs are increasingly used in patients with type 2 diabetes. We compared the effect of basal, biphasic, prandial, and basal-bolus insulin regimens with insulin analogs to reach the hemoglobin A1c (HbA1c) target of ,7% in people with type 2 diabetes. We conducted an electronic search for randomized controlled trials (RCTs) involving insulin analogs. RCTs were included if they lasted at least 12 weeks, reported the proportion of diabetic patients reaching the HbA1c target of 7% (primary outcome), and the number of patients in any arm was30. We found 16 RCTs,with 20 comparisons and 7,7